business

Wedbush upgrades Abivax stock rating on trial data, cuts target

Investing.com · Jun 2, 2026, 12:26 PM · Also reported by 1 other source

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance H.C. Wainwright Raises Price Target on Immunovant (IMVT) Following Positive Rheumatoid Arthritis Trial Data

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Wedbush upgrades Abivax stock rating on trial data, cuts target

Also covered by

More in business